Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2011 051 447.4 |
96 | EP file number | EAKZ | 16 18 7411.0 |
97 | EP publication number | EPN | 3127542 |
54 | Designation/title | TI | ANTIVIRALE THERAPIE |
51 | IPC main class | ICM (ICMV) | A61K 31/5365 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/52 (2006.01), A61P 31/18 (2006.01) |
22 | DE application date | DAT | Jan 24, 2011 |
96 | EP application date | EAT | Jan 24, 2011 |
43 | Date of first publication | OT | Feb 8, 2017 |
| Date of publication of grant | PET | Aug 22, 2018 |
71/73 | Applicant/owner | INH | VIIV Healthcare Company, Wilmington, Del., US |
72 | Inventor | IN | UNDERWOOD, Mark Richard, Research Triangle Park, NC North Carolina 27709, US |
74 | Representative | VTR | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 298589 P Jan 27, 2010
|
| Due date | FT FG | Jan 31, 2026 Annual fee for the 16th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003127542A1 Searchable text:
EP000003127542A1 Original document:
EP000003127542B1 Searchable text:
EP000003127542B1 |
43 | Date of first publication | EVT | Feb 8, 2017 |
| Date of the first transfer into DPMAregister | EREGT | Feb 9, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 11, 2025 (Show all update days)(Hide all update days)- Jan 11, 2025
- Due date: changed
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 10.10.2024: changed
- Jan 2, 2025
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 10.10.2024: new
- Procedures: Opposition procedure, Patent maintained in full by EPO, 10.10.2024: new
- Nov 12, 2024
- May 30, 2024; Jan 6, 2024; Jan 14, 2023; Dec 22, 2021; Jan 14, 2021; Dec 1, 2020; Jan 11, 2020; Aug 23, 2019; Jul 11, 2019; Jun 6, 2019; Jan 5, 2019; Oct 24, 2018; Sep 20, 2018; Aug 10, 2018; Aug 9, 2018; Jun 14, 2017
- Historical data not available for this/these date(s)
- Feb 9, 2017
- Date of the first transfer into DPMAregister
|